GSK GLAXF Stock
GSK Price Chart
GSK GLAXF Financial and Trading Overview
| GSK stock price | 20.07 USD |
| Previous Close | 17.7 USD |
| Open | 17.55 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 17.17 - 17.55 USD |
| 52 Week Range | 13.48 - 22.67 USD |
| Volume | 1.3K USD |
| Avg. Volume | 2.2K USD |
| Market Cap | 70.31B USD |
| Beta (5Y Monthly) | 0.307662 |
| PE Ratio (TTM) | 12.625 |
| EPS (TTM) | 1.5 USD |
| Forward Dividend & Yield | 0.7 (3.96%) |
| Ex-Dividend Date | May 18, 2023 |
| 1y Target Est | N/A |
GLAXF Valuation Measures
| Enterprise Value | 85.12B USD |
| Trailing P/E | 12.625 |
| Forward P/E | 8.896374 |
| PEG Ratio (5 yr expected) | 8627.11 |
| Price/Sales (ttm) | 2.4174309 |
| Price/Book (mrq) | 5.886184 |
| Enterprise Value/Revenue | 2.927 |
| Enterprise Value/EBITDA | 8.829 |
Trading Information
GSK Stock Price History
| Beta (5Y Monthly) | 0.307662 |
| 52-Week Change | -16.73% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 22.67 USD |
| 52 Week Low | 13.48 USD |
| 50-Day Moving Average | 17.95 USD |
| 200-Day Moving Average | 16.97 USD |
GLAXF Share Statistics
| Avg. Volume (3 month) | 2.2K USD |
| Avg. Daily Volume (10-Days) | 1.22K USD |
| Shares Outstanding | 4.09B |
| Float | 3.92B |
| Short Ratio | N/A |
| % Held by Insiders | 1.74% |
| % Held by Institutions | 43.27% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.578 |
| Trailing Annual Dividend Yield | 3.26% |
| 5 Year Average Dividend Yield | 527.00% |
| Payout Ratio | 0.56299996 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 50.34% |
| Operating Margin (ttm) | 25.00% |
| Gross Margin | 70.34% |
| EBITDA Margin | 33.14% |
Management Effectiveness
| Return on Assets (ttm) | 6.13% |
| Return on Equity (ttm) | 28.17% |
Income Statement
| Revenue (ttm) | 29.08B USD |
| Revenue Per Share (ttm) | 7.21 USD |
| Quarterly Revenue Growth (yoy) | -3.30% |
| Gross Profit (ttm) | 19.92B USD |
| EBITDA | 9.64B USD |
| Net Income Avi to Common (ttm) | 4.46B USD |
| Diluted EPS (ttm) | 1.36 |
| Quarterly Earnings Growth (yoy) | -17.29% |
Balance Sheet
| Total Cash (mrq) | 6.98B USD |
| Total Cash Per Share (mrq) | 1.72 USD |
| Total Debt (mrq) | 20.91B USD |
| Total Debt/Equity (mrq) | 184.8 USD |
| Current Ratio (mrq) | 0.953 |
| Book Value Per Share (mrq) | 2.917 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.91B USD |
| Levered Free Cash Flow (ttm) | 3.25B USD |
Profile of GSK
| Country | United States |
| State | N/A |
| City | Brentford |
| Address | 980 Great West Road |
| ZIP | TW8 9GS |
| Phone | 44 20 8047 5000 |
| Website | https://www.gsk.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | 69400 |
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
Q&A For GSK Stock
What is a current GLAXF stock price?
GSK GLAXF stock price today per share is 20.07 USD.
How to purchase GSK stock?
You can buy GLAXF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GSK?
The stock symbol or ticker of GSK is GLAXF.
Which industry does the GSK company belong to?
The GSK industry is Drug Manufacturers-General.
How many shares does GSK have in circulation?
The max supply of GSK shares is 4.16B.
What is GSK Price to Earnings Ratio (PE Ratio)?
GSK PE Ratio is 13.38000000 now.
What was GSK earnings per share over the trailing 12 months (TTM)?
GSK EPS is 1.5 USD over the trailing 12 months.
Which sector does the GSK company belong to?
The GSK sector is Healthcare.